NCT04017819View on ClinicalTrials.gov

Biodistribution&Pharmacokinetic of Position Emission Tomography(PET) Radiopharmaceutical 18F C SNAT4

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 7, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
CancerLung Cancer
Interventions
DRUG

18F-C-SNAT4

Radiotracer- Dose 10 mCi

DEVICE

Positron emission tomography (PET)/Computed tomography (CT) Scan

Positron emission tomography (PET)/Computed tomography (CT) Scan

Trial Locations (1)

94304

Stanford University, Stanford

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Stanford University

OTHER

NCT04017819 - Biodistribution&Pharmacokinetic of Position Emission Tomography(PET) Radiopharmaceutical 18F C SNAT4 | Biotech Hunter | Biotech Hunter